Polar Capital Holdings’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.4M | Sell |
3,999,338
-356,626
| -8% | -$3.16M | 0.19% | 107 |
|
|
2025
Q1 | $34.1M | Sell |
4,355,964
-58,236
| -1% | -$456K | 0.21% | 117 |
|
|
2024
Q4 | $46.4M | Sell |
4,414,200
-419,828
| -9% | -$4.41M | 0.26% | 96 |
|
|
2024
Q3 | $63.4M | Sell |
4,834,028
-1,726,387
| -26% | -$22.6M | 0.3% | 70 |
|
|
2024
Q2 | $92.2M | Sell |
6,560,415
-193,257
| -3% | -$2.72M | 0.54% | 50 |
|
|
2024
Q1 | $114M | Buy |
6,753,672
+1,890
| +0% | +$31.9K | 0.6% | 39 |
|
|
2023
Q4 | $95.3M | Buy |
6,751,782
+2,238,818
| +50% | +$31.6M | 0.58% | 49 |
|
|
2023
Q3 | $46.5M | Sell |
4,512,964
-21,957
| -0.5% | -$226K | 0.34% | 79 |
|
|
2023
Q2 | $74.7M | Sell |
4,534,921
-37,569
| -0.8% | -$619K | 0.38% | 64 |
|
|
2023
Q1 | $41.9M | Buy |
4,572,490
+1,760,000
| +63% | +$16.1M | 0.27% | 91 |
|
|
2022
Q4 | $20.1M | Hold |
2,812,490
| – | – | 0.16% | 148 |
|
|
2022
Q3 | $14.1K | Hold |
2,812,490
| – | – | 0.09% | 165 |
|
|
2022
Q2 | $6.86K | Sell |
2,812,490
-386,662
| -12% | -$943 | 0.04% | 223 |
|
|
2022
Q1 | $21.9K | Buy |
3,199,152
+404,479
| +14% | +$2.76K | 0.1% | 162 |
|
|
2021
Q4 | $22.6K | Hold |
2,794,673
| – | – | 0.08% | 157 |
|
|
2021
Q3 | $27.4K | Hold |
2,794,673
| – | – | 0.11% | 142 |
|
|
2021
Q2 | $18.8K | Hold |
2,794,673
| – | – | 0.08% | 173 |
|
|
2021
Q1 | $25.3M | Sell |
2,794,673
-233,032
| -8% | -$2.11M | 0.16% | 136 |
|
|
2020
Q4 | $20.2M | Buy |
+3,027,705
| New | +$20.2M | 0.12% | 156 |
|